ArticleWorld journal of gastroenterology2022

No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer.

Yun-Zi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.